FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy, Françoise Desseigne, Marc Ychou, +17

New England Journal of Medicine

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Pascal Hammel, Mohamed Hebbar, +29

New England Journal of Medicine

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial

Thierry Conroy, Jean-François Bosset, Pierre-Luc Etienne, +54

The Lancet Oncology

Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

Sherene Loi, Damien Drubay, Sylvia Adams, +19

Journal of Clinical Oncology

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial

François Quénet, Dominique Élias, Lise Roca, +20

The Lancet Oncology

Cytoreductive SurgerySurgical OncologyProdige 7Gastrointestinal OncologyColorectal Surgery +6

Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study

Thomas Bachelot, Gilles Romieu, Mario Campone, +13

The Lancet Oncology

Breast OncologyBrain MetastasesMedicineCancer ManagementPharmacology +6

Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial

Gwénaëlle Gravis, Karim Fizazi, Florence Joly, +29

The Lancet Oncology

Androgen-deprivation TherapyUrologyGenitourinary CancerMedicineGetug-afu 15 +5

Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design

Karim Fizazi, Stéphanie Foulon, Joan Carles, +29

The Lancet

Factorial DesignUrology× 2Genitourinary CancerDeprivation Therapy +7

Genomic characterization of metastatic breast cancers

François Bertucci, Charlotte K.Y. Ng, Anne Patsouris, +25

Nature

Breast OncologyOncologyMedicineCancer GenomicsBreast Cancer +3

Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study

Julien Edeline, M. Benabdelghani, Aurélie Bertaut, +20

Journal of Clinical Oncology